Practice question

Answer the question and get instant feedback.

MediumEndocrinologyType 2 diabetes with cardiovascular diseaseca-mccqe1ca-rcpsc-im

A 65-year-old man with type 2 diabetes, obesity, and established coronary artery disease has an HbA1c of 7.8% on maximal tolerated metformin. eGFR is 60 mL/min/1.73 m². According to Diabetes Canada, which additional agent is preferred for cardiovascular risk reduction?

Educational content. Not a substitute for clinical judgement or local policy.